Suheung Co., Ltd. (KRX:008490)
15,950
+250 (1.59%)
Feb 20, 2025, 9:00 AM KST
Suheung Revenue
Suheung had revenue of 166.59B KRW in the quarter ending September 30, 2024, with 9.38% growth. This brings the company's revenue in the last twelve months to 637.90B, up 7.59% year-over-year. In the year 2023, Suheung had annual revenue of 594.57B, down -6.36%.
Revenue (ttm)
637.90B
Revenue Growth
+7.59%
P/S Ratio
0.29
Revenue / Employee
866.72M
Employees
736
Market Cap
187.91B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 594.57B | -40.40B | -6.36% |
Dec 31, 2022 | 634.97B | 38.23B | 6.41% |
Dec 31, 2021 | 596.73B | 43.72B | 7.91% |
Dec 31, 2020 | 553.01B | 92.28B | 20.03% |
Dec 31, 2019 | 460.73B | 67.25B | 17.09% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,364.39B |
Celltrion | 2,876.25B |
SK Biopharmaceuticals | 511.33B |
Yuhan | 2,008.84B |
SK bioscience | 201.30B |
Hanmi Pharm. | 1,495.50B |
Hanmi Science | 1,283.65B |
Hanall Biopharma | 134.24B |